Covid-19: Lopinavir-ritonavir does not benefit hospitalised patients, UK trial finds
Shaun Griffin
Abstract
Covid-19: Lopinavir-ritonavir does not benefit hospitalised patients, UK trial finds
Topics & Concepts
LopinavirRitonavirLopinavir/ritonavirCoronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicVirologyPediatricsIntensive care medicineInternal medicineHuman immunodeficiency virus (HIV)Viral loadOutbreakAntiretroviral therapyDiseaseInfectious disease (medical specialty)Infectious Encephalopathies and EncephalitisDrug-Induced Hepatotoxicity and ProtectionCOVID-19 Clinical Research Studies